Emcure partners Roche to distribute kidney transplant and anemia therapies in India

admin
March 2, 2026
Uncategorized

Emcure Pharmaceuticals signs a distribution deal with Roche to supply CellCept, Mircera, and Neorecormon for nephrology and transplant care in India, effective April 1, 2026.

Emcure partners Roche to distribute kidney transplant and anemia therapies in India

Leave a ReplyCancel Reply

Citi remains cautious on Indian IT despite a 20% fall, prefers these two names

Explained — How rising oil prices will have a negative impact on shares of IndiGo

Iran-Israel-US War: KRBL, LT Foods fall up to 8% as rice export worries hit

Stock Market Sell-Off: Here’s a list of stocks impacted due to the Iran war

Rupee weakens amid rising crude prices, RBI likely steps in to curb volatility